Molecular Partners Financials - Benzinga

Molecular Partners AG

MOLNNASDAQ

Trade with Public

Trade with Public

$4.13

Last update: Aug 11, 4:00 AM

Earnings: Q2 2026 Earnings in 12 days from now on Tue Aug 25th, after the market close

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

Molecular Partners Financials

Molecular Partners (MOLN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Molecular Partners Q1 EPS $(0.45) Misses $(0.38) Estimate

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.38) by 18.42 percent. This is a 11.76 percent increase over losses of $(0.51) per share

Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

PRO
Molecular Partners Q4 EPS $(0.41) Misses $(0.38) Estimate.

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.38) by 7.89 percent.

Benzinga Newsdesk

Earnings Scheduled For March 12, 2026

Benzinga Insights

PRO
Molecular Partners Q3 EPS $(1.65) Misses $(0.46) Estimate

Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(1.65) per share which missed the analyst consensus estimate of $(0.46) by 258.7 percent.

Benzinga Newsdesk

PRO
Molecular Partners Q2 EPS $(0.67) Down from $(0.56) YoY

Molecular Partners (NASDAQ:MOLN) Q2 EPS $(0.67) Down from $(0.56) YoY

Benzinga Newsdesk